Ocular Therapeutix, Inc. (OCUL) announced on Monday that President and CEO Antony Mattessich will be stepping down.
Mattessich is being succeeded by Pravin Dugel, executive chairman, who will assume the roles of president and CEO, effective immediately.
In addition to these new responsibilities, Dugel will maintain his positions as a director and executive chairman of the company.
Dugel has previously served in leadership roles such as President of Iveric Bio, Inc.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.